Lipoprotein(a) (Lp(a)) is becoming increasingly important as an independent risk factor for cardiovascular disease. Since no effective therapy currently exists other than lipid apheresis, the recommendation remains to optimally adjust all other cardiovascular risk factors (CVRF). In a Northwest German population study, the frequency of elevated Lp(a) levels and all other CVRF was investigated. The aim was to investigate whether individuals with elevated Lp(a) levels were also more likely to have other CVRFs. To date, 4602 individuals have been enrolled in the study, and blood pressure, weight, lipids, diabetes, medications, and pre-existing conditions were recorded in addition to Lp(a). In addition, questionnaires assessed physical activity, psychological stress, depression, and brain dysfunction. All participants received detailed individual recommendation about their CVRF and its treatment. In the further follow-up of 5 years, it will be examined how persons with elevated Lp(a) implemented these recommendations in comparison with participants without elevated Lp(a). The first group Lp(a) <75 nmol/L consisted of 3550 (80.2%), the Lp(a) 75-120 nmol/L group of 341 (7.4%) and the Lp(a) >120 nmol/L of 538 (11.7%). 81.6% of all participants had one or more CVRF. Age, sex, and prevalence of hypertension, diabetes, smoking, obesity, and exercise did not differ among the 3 groups. As expected, LDL-Cholesterol was significantly elevated in the Lp(a) >120 nmol/L group despite significantly more frequent use of statins. Significantly more often hypertensive patients were found in the Lp(a) >120 nmol/L group who were inadequately controlled by medication and significantly less often persons without further CVRF. No differences existed in the frequency of psychological stress, depression, and mild cognitive impairment. CVRF occur with comparable frequency in individuals with elevated Lp(a) levels. However, individuals with Lp(a) above 120 nmol/L were more likely to have poorly controlled blood pressure, elevated LDL-C, and less likely to have no other risk factors. This underlines that in case of Lp(a) elevation all further CVRF should be intensively adjusted, especially in case of strongly elevated values >120 nmol/L. However, these recommendations have not been adequately implemented in clinical care in this population to date., Competing Interests: The study is supported personally or financially by numerous regional and national companies and institutions (in alphabetical order): AOK – Die Gesundheitskasse für Niedersachsen, Sevelter Str. 40, 49661 Cloppenburg B. Braun Melsungen AG, Carl-Braun-Straße 1, 34212 Melsungen Big Dutchman International GmbH, Auf der Lage 2,49377 Vechta-Calveslage, Bilfinger EMS GmbH, 49661 Cloppenburg Biochem Zusatzstoffe Handels- und Produktionsges. mbH, Küstermeyerstr. 16, 49393 Lohne Böckmann Fahrzeugwerk GmbH, Siehefeld 5, 49688 Lastrup Brand Qualitätsfleisch GmbH & Co.KG, Brandstr. 21,49393 Lohne, DiNo 1 GmbH, Mühlenstr. 10, 49661 Cloppenburg, Elektro Koopmann GmbH, Zum Brook 19 – 21, 49661 Cloppenburg, Fleming & Wendeln GmbH & Co. KG, Auf’m Halskamp 12, 49681 Garrel, Gemüsebau Mählmann, Im Siehenfelde 13, 49692 Cappeln Hans und Marlies Stock-Stiftung, Köln, c/o DSZ, Bark- hovenallee 1, 45239 Essen, Heidemark GmbH, Lether Gewerbestr. 2, 26197 Ahlhorn Jungpflanzen Lüske, Josef, Kirchstr. 29, 49685 Höltinghausen Moorgut Katrzfehn von Kameke GmbH & Co. KG, Kartz-von- Kameke-Allee 7, 26219 Bösel, Paul Lüske GmbH, Mercedes, Emsteker Str. 95, 49661 Cloppenburg, Sanofi-Aventis Deutschland GmbH, Potsdamer Str. 8a, 10785 Berlin Servier Deutschland GmbH, Elsenheimerstr. 53, 80687 München, Sieverding Heizungs- und Sanitärtechnik GmbH, Tenstedter Str. 40, 49692 Cappeln, St.-Josefs Hospital Cloppenburg gGmbH, Krankenhausstr. 13, 49661 Cloppenburg, Stevens Truthahn-Delikatessen GmbH, Vahrener Weg 1,49696 Molbergen, Weigel, Werner, Teichstr. 13, 49661 Cloppenburg Wernsing Feinkost GmbH, Kartoffelweg 1, 49632 Addrup. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results., (© 2021 The Author(s). Published by IMR Press.)